Trial Profile
Efficacy and Safety of Analgecine for Low Back Pain: a Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs AGC (Primary) ; Neurotropin
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Vanworld Pharmaceutical Rugao
- 08 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jun 2014 New trial record